One year after endoscopic sinus surgery in polyposis: asthma, olfaction, and quality-of-life outcomes

Otolaryngol Head Neck Surg. 2012 May;146(5):834-41. doi: 10.1177/0194599811435638. Epub 2012 Jan 27.

Abstract

Objective: Nasal polyposis is a disease known to be associated with asthma. The long-term effects of surgical treatment on lower airways have not been sufficiently studied.

Study design: One-year follow-up of a double-blind, randomized, placebo-controlled study.

Setting: The study was conducted at the Karolinska University Hospital, Stockholm, Sweden.

Subjects and methods: Fifty-one patients, age 18 years or older, with nasal polyposis and asthma were evaluated 1 year after endoscopic sinus surgery (ESS). Outcomes included dyspnea/cough scores, mean daily peak expiratory flow rate, spirometry, butanol test, olfaction scores, peak nasal inspiratory flow, polyp scores, and health-related quality of life (SF-36).

Results: The short-term postsurgery improvements in asthma symptom scores, daily peak expiratory flow rate, all nasal parameters including olfaction, and quality-of-life scores were generally maintained 1 year after ESS.

Conclusion: Endoscopic sinus surgery had beneficial long-term effects on asthma, olfaction, and quality of life in patients with nasal polyposis. This is the first study to show long-term benefits of ESS on butanol tests in patients with nasal polyposis.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Asthmatic Agents / administration & dosage
  • Asthma / drug therapy
  • Asthma / prevention & control*
  • Double-Blind Method
  • Endoscopy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Nasal Polyps / physiopathology
  • Nasal Polyps / surgery*
  • Paranasal Sinuses / surgery*
  • Placebos
  • Quality of Life*
  • Respiratory Function Tests
  • Severity of Illness Index
  • Smell / physiology*
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Placebos